We are live on
!
Find out more
Bioventus
BVS
BVS
102 hedge funds and large institutions have $222M invested in Bioventus in 2024 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 30 increasing their positions, 20 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
105% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 19
50% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 20
25% more capital invested
Capital invested by funds: $178M → $222M (+$43.9M)
21% more funds holding
Funds holding: 84 → 102 (+18)
6.45% more ownership
Funds ownership: 54% → 60.46% (+6.5%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
31% less call options, than puts
Call options by funds: $877K | Put options by funds: $1.28M
Holders
102
Holders Change
+18
Holders Change %
+21.43%
% of All Funds
1.47%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
39
Increased
30
Reduced
20
Closed
19
Calls
$877K
Puts
$1.28M
Net Calls
-$403K
Net Calls Change
-$476K
Top Buyers
| 1 |
BlackRock
New York
|
+$10.1M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.47M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.43M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$2.37M |
| 5 |
Renaissance Technologies
New York
|
+$2.21M |
